{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Evidence-Based Updates to the 2021 Surviving Sepsis Campaign Guidelines Part 1: Background, Pathophysiology, and Emerging Treatments

Activity Steps

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Identify the background, pathophysiology, and risk factors for the development of sepsis.
  2. Describe sepsis treatment and recovery, including review of 2021 guidelines.
  3. Explain diagnostic criteria and both the current and emerging biomarkers for the recognition of sepsis.

Learning Outcomes

Seventy-five percent of participants will be able to demonstrate an increase in knowledge about evidence-based updates to the 2021 Surviving Sepsis Campaign guidelines to understand background, pathophysiology, and emerging treatments by achieving a posttest score of 70% or greater.
Price: $17.95

Credits:

  • ANCC 1.5 CH
  • DC - BON 1.5 CH
  • FL - BON 1.5 CH
  • GA - BON 1.5 CH
  • NM - BON 1.5 CH
  • SC - BON 1.5 CH
  • WV - BOERN 1.5 CH

Lippincott Professional Development is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, Georgia Board of Nursing, New Mexico Board of Nursing, South Carolina Board of Nursing, and West Virginia Board of Examiners for Registered Professional Nurses, #50-1223.













Test Code: NP1122A
Published: Nov 2022
Expires: 9/5/2025
Required Passing Score: 8/10 (80%)
Authors: Karen D. Lehman, DNP, APRN-BC